Skip to main content
SpringerLink
Log in

Antiepileptische Therapie

  • Chapter
Epileptische Anfälle

  • 14 Accesses

Zusammenfassung

Der Entscheid darüber, ob und gegebenenfalls wie ein Patient mit epilepsieverdôchtige Anfällen behandelt werden soll, wird erst dann gefaßt, wenn der Arzt die im Kapitel II erwähnten diagnostischen Probleme gelöst hat. Dabei ist folgendes zu berücksichtigen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel VIII

  1. Agarwal BN, Cabebe FG, Hoffmann BJ (1977) Diphenylhydantoin - induced acute renal failure. Nephron 18:249–251

    Article  PubMed  CAS  Google Scholar 

  2. Albert J, Waldburger M (1983) Forme chronique D’algoneurodystrophie secondaire au traitement de phénobarbital. Rev med (Praxis) 24:1679–1682

    Google Scholar 

  3. Arbeitsgruppe für das AFP-Screening in der Schweiz (1985) Früherfassung kindlicher Miß-bildungen des Rückenmarkes und des Gehirns: Das AFP-Screening - Ergebnisse einer Studie bei 16000 schwangeren Frauen in der Schweiz. Schweiz Aerzte Ztg 66:274–284

    Google Scholar 

  4. Asconapé JJ, Penry JK (1982) Use of antiepileptic drugs in the presence of liver and kidney disease: A review. Epilepsia 23 (Suppl 1) 65–79

    Article  Google Scholar 

  5. Back DJ, Bates M, Bowden A, Breckenridge AM, Hall MJ, Jones H, Maclever M, Orme M, Perucca E, Richens A, Rowe PH, Smith E (1980) The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception 22:495–503

    Article  PubMed  CAS  Google Scholar 

  6. Ballenger CE, Lucke JF, King DW, Gammal TE, Brooks BS, Green JB (1982) Cerebellar atrophy in epilepsy and headache: Lack of relationship to phenytoin. Neurology 32:910– 912

    PubMed  Google Scholar 

  7. Bar S, Feller N, Savir H (1983) Presenil cataracts in phenytoin-treated epileptic patients. Arch Ophthalmol 101:422–425

    Article  PubMed  CAS  Google Scholar 

  8. Battino D, Avanzini G, Bossi L, Canger R, Como ML, Croci D, Spina S (1982) Monitoring of antiepileptic drugs plasma levels during pregnancy and puerperium. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 147–154. Raven Press, New York

    Google Scholar 

  9. Battino D, Binelli S, Bossi L, Como ML, Croci D, Cusi C, Avanzini G (1984) Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium. Clin Pharmacokin 9:252–260

    Article  CAS  Google Scholar 

  10. Beck-Mannagetta G, Drees B, Janz D (1982) Malformations and minor anomalies in the offspring of epileptic parents: a retrospective study. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 317–323. Raven Press, New York

    Google Scholar 

  11. Bickerstaff ER (1975) Neurological complications of oral contraceptives. Clarendon Press, Oxford

    Google Scholar 

  12. Bing R (1940) Lehrbuch der Nervenkrankheiten. 6. Auflage, p. 585–588. Schwabe, Basel

    Google Scholar 

  13. Bjerkedal T, Czeizel A, Goujard J, Kallen B, Mastroiacova P, Nevin N, Oakley G, Robert E (1982) Valproic acid and spina bifida. Lancet II/1096 u. 1172

    Article  Google Scholar 

  14. Blom S (1962) Trigeminal neuralgia: Its treatment with a new anticonvulsant drug (G-32883). Lancet 1/839–840

    Article  PubMed  CAS  Google Scholar 

  15. Boenigk HE, Lorenz JH, Jürgens U (1984) Aktuelle Erfahrungen mit Bromiden zur Behandlung generalisierter Epilepsien. 25. Jubiläumstagung der Deutschen Sektion der Intern. Liga gegen Epilepsie in Kehl. Zusammenfassungen der Referate, S 139

    Google Scholar 

  16. Bonduelle M, Bouygues P, Sallou C, Chemaly R (1964) Bilan de 1’expérimentation clinique de 1’anti-épileptique G 32883 [5-Carbamoyl-5-H-dibenzo-(b, f) azépine]. Résultats de 89 observations. In: Bradley PB, Flügel F, Hock PH (eds) Proc. ITI Congr. Intern. Neuro-Psy-chopharmac. München 1962, Vol. 3, p. 312–315. Elsevier, Amsterdam

    Google Scholar 

  17. Bonkowsky HL (1981) Carbamazepine in seizure management in acute intermittent porphyria. Reply from the author. Neurology 31:1579

    Google Scholar 

  18. Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF (1980) Seizure management in acute hepatic porphyria: Risks of valproate and clonazepam. Neurology 30:588–592

    PubMed  CAS  Google Scholar 

  19. Bonkowsky HL, Shedlofsky SI, Sinclair PR (1982) Seizure management and hepatic porphyrias. Reply from the authors. Neurology 32:1410

    Google Scholar 

  20. Booker HE (1972) Primidone. Relation of plasma levels to clinical control. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 373–376. Raven Press, New York

    Google Scholar 

  21. Booker HE (1972) Primidone. Toxicity. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 377–383. Raven Press, New York

    Google Scholar 

  22. Bossi L (1982) Neonatal period including drug disposition in newborns: Review of literature. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 327–341. Raven Press, New York

    Google Scholar 

  23. Browning RA, Maynert EW (1972) Phenobarbital, mephobarbital and metharbital. Toxicity. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 345–351. Raven Press, New York

    Google Scholar 

  24. Buchanan RA (1972) Ethosuximide. Toxicity. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepiletic Drugs, p. 449–454. Raven Press, New York

    Google Scholar 

  25. Burgess ED, Friel PN, Blair AD, Raisy VA (1981) Serum phenytoin concentrations in uremia. Ann Intern Med 94:59–60

    PubMed  CAS  Google Scholar 

  26. Calmeil LF (1824) De l’épilepsie, étudiée sous le rapport de son siège et de son influence sur la production de l’aliénation mentale. These. Didot le jeune, Paris

    Google Scholar 

  27. Chadwick D, Reynolds EH, Marsden CD (1976) Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol, Neurosurg, Psychiatr 39:1210–1218

    Article  CAS  Google Scholar 

  28. Chadwick D, Shaw MDM, Foy P, Rawlins MD, Turnbull DM (1984) Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. Neurol Neurosurg Psychiat 47:642–644

    Article  CAS  Google Scholar 

  29. Chalk JB, Ridgeway K, Brophy T, Yelland JDN, Eadie MJ (1984) Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol, Neurosurg, Psychiat 47:1087–1090

    Article  CAS  Google Scholar 

  30. Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC (1982) Mechanisms of anticonvulsant action of valproate. Progr Neurobiol 19:315–359

    Article  CAS  Google Scholar 

  31. Christiansen C, Rodbro P, Tjellesen L (1983) Pathophysiology behind anticonvulsant osteomalacia. Acta Neurol Scand 67, Suppl 94:21–28

    Google Scholar 

  32. Cleland P (1983) The female with epilepsy: pros and cons of anticonvulsant therapy. In: Jeavons PM, Anfield L (eds) Third International Symposium on Sodium Valproate. Br J Clin Pract, Symp Suppl 27:42–47

    Google Scholar 

  33. Clifford DB (1984) Seizures and pregnancy. Am Fam Physician 29:271–275

    PubMed  CAS  Google Scholar 

  34. Committee on Drugs (1982) Valproic acid: Benefits and risks. Pediatrics 70:316–318

    Google Scholar 

  35. Coulam CB, Annegers JF (1979) Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 20:519–526

    Article  PubMed  CAS  Google Scholar 

  36. Coulter DL, Allen RJ (1979) Pancreatitis associated with valproic acid therapy for Epilepsy. Ann Neurol 7:92

    Article  Google Scholar 

  37. Dam M (1972) Diphenylhydantoin. Neurologic Aspects of Toxicity. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 227–235. Raven Press, New York

    Google Scholar 

  38. Dam M, Dam AM (1984) Epilepsie et grossesse. Epilepsie-Informationsblatt der Schweizerischen Liga gegen Epilepsie 4:2–11

    Google Scholar 

  39. Danner R (1983) Nebenwirkungen von Phenytoin und Carbamazepin auf elektrophysiologische Funktionen des peripheren Nervensystems. Nervenarzt 54:530–534

    PubMed  CAS  Google Scholar 

  40. Dansky L, Andermann E, Shervin AL, Andermann F (1982) Plasma levels of phenytoin during pregnancy and puerperium. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 155–162. Raven Press, New York

    Google Scholar 

  41. Dayer P (1982) Einige klinische Untersuchungen zur Behandlung von Patienten mit Niereninsuffizienz. Sandorama 1:40–42

    Google Scholar 

  42. Deisenhammer E, Schwarzbach H, Sommer R (1982) Erhöhung der Gamma-GT bei antikonvulsiver Therapie. Wien klin Wschr 94:584–585

    PubMed  CAS  Google Scholar 

  43. Delgado-Escueta AV, Wasterlan C, Treiman DM, Porter RJ (1982) Current concepts in neurology: Management of status epilepticus. N Engl J Med 306:1337–1340

    Article  PubMed  CAS  Google Scholar 

  44. Delgado-Escueta AV, Treiman DM, Walsh GO (1983) The treatable epilepsies. Second of two parts (1983) N Engl J Med 308:1576–1584

    Article  PubMed  CAS  Google Scholar 

  45. Dutton P (1958) Phenytoin toxicity with associated meningeal reaction. J Ment Sci 104:1165–1166

    PubMed  CAS  Google Scholar 

  46. Editorial (1982) Valproate and malformations. Lancet 11/1313–1314

    Google Scholar 

  47. Egenaes J (1982) Outcome of pregnancy in women with epilepsy - Norway, 1967 to 1978: Complications during pregnancy and delivery. In: Janz D et al (eds) Epilepsie, Pregnancy and the Child, p. 81–90. Raven Press, New York

    Google Scholar 

  48. Egerton Vernon JM, Fisk MJ, Snell AP (1983) Phenytoin-induced hepatotoxity. N Z Med J 96:467–469

    PubMed  CAS  Google Scholar 

  49. Encinoza O (1974) Nerve conduction velocity in patients on long-term diphenylhydantoin therapy. Epilepsia 15:147–154

    Article  PubMed  CAS  Google Scholar 

  50. Fabro S, Brown NA (1979) Teratogenic potential of anticonvulsants. N Engl J Med 300:1280–1281

    PubMed  CAS  Google Scholar 

  51. Fedrick J (1973) Epilepsy and pregnancy: A report from Oxford record linkage study. Br Med J 2:442–448

    Article  PubMed  CAS  Google Scholar 

  52. Ferrendelli JA, Kupferberg HJ (1980) Antiepileptic Drugs. Succinimides. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol 27:587–596. Raven Press, New York

    Google Scholar 

  53. Fincham RW, Schottelius DD, Sahs AL (1974) The influence of diphenylhydantoin on primidone metabolism. Arch Neurol (Chicago) 30:259–262

    Article  CAS  Google Scholar 

  54. Finnell RJ, Chernoff GF (1984) Editorial comment: Genetic background: The elusive component in the fetal hydantoin syndrome. Am J Medic Genet 19:459–162

    Article  CAS  Google Scholar 

  55. Finnell RJ, Chernoff GF (1984) Variable patterns of malformation in the mouse fetal hydantoin syndrome. Am J Medic Genet 19:463–471

    Article  CAS  Google Scholar 

  56. Friis ML (1983) Antiepileptic drugs and teratogenesis. How should patients, doctors and authorities be counselled? Acta Neurol Scand 67, Suppl 94:39–43

    Google Scholar 

  57. Fröscher W (1976) Therapie des Status epilepticus. Schattauer, Stuttgart New York

    Google Scholar 

  58. Fröscher W, Hoffmann F (1983) Dupuytrensche Kontraktur und Phenobarbitaleinnahme bei Epilepsie-Patienten. Nervenarzt 54:413–419

    PubMed  Google Scholar 

  59. Fuchs T, Seubert A, Seubert S, Ippen H (1980) Anticonvulsant-induced unclassified porphyria. Int J Biochem 12:955–957

    Article  PubMed  CAS  Google Scholar 

  60. Gallagher BB, Baumel IP (1972) Primidone. Absorption, distribution, and excretion. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 357–359. Raven Press, New York

    Google Scholar 

  61. Gallagher BB, Baumel IP (1972) Primidone. Biotransformation. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 361–366. Raven Press, New York

    Google Scholar 

  62. Gambertoglio JG, Lauer RM (1981) Use of neuropsychiatric drugs. In: Anderson RJ, Schreier RW (eds) Clinical Use of Drugs in Patient with Kidney and Liver Disease, p. 276– 295. Saunders, Philadelphia-London-Toronto-Sydney

    Google Scholar 

  63. Gancher S, Laxer KD, Krieger W (1984) Activation of epileptogenic activity by etomidate. Anesthesiology 61:616–618

    Article  PubMed  CAS  Google Scholar 

  64. Gastaut H (1976) Wörterbuch der Epilepsie. Deutsche Übersetzung und Bearbeitung von J. Kugler. Hippokrates, Stuttgart

    Google Scholar 

  65. Gates JR, Leppik IE, Yap J, Gumnit RJ (1984) Corpus callosotomy: Clinical and electroencephalographic effects. Epilepsia 25:308–316

    Article  PubMed  CAS  Google Scholar 

  66. Geraldini C, Faedda MT, Sideri G (1984) Anticonvulsant therapy and its possible consequences on peripheral nervous system: A neurographic study. Epilepsia 25:502–505

    Article  PubMed  CAS  Google Scholar 

  67. German I, Kowal A, Ehlers KH (1970) Trimethadione and human teratogenesis. Teratology 3:349–361

    Article  PubMed  CAS  Google Scholar 

  68. Gerson WT, Fine DG, Spielberg SP, Sensenbrenner LL (1983) Anticonvulsant-induced aplastic anemia: Increased susceptibility to toxic drug metabolites in vitro. Blood 61:889– 893

    PubMed  CAS  Google Scholar 

  69. Glaser GH (1972) Diphenylhydantoin. Toxicity. In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 219–226. Raven Press, New York

    Google Scholar 

  70. Goldberg MA (1980) Phenytoin: Binding. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol.27: p. 323–337. Raven Press, New York

    Google Scholar 

  71. Goldberg MA (1980) Phenobarbital: Binding. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol. 27: p. 501– 504. Raven Press, New York

    Google Scholar 

  72. Goldring JM, Blaustein MP (1980) Barbiturates: Physiological effects II. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol. 27: p. 523–531. Raven Press, New York

    Google Scholar 

  73. Gram L, Bentsen KD (1984) Controlled and comparative trials of valproate performed in Europa and Asia. Epilepsia 25 (Suppl 1):32–39

    Article  Google Scholar 

  74. Halama P (1984) Chronische Hepatopathien durch Antikonvulsiva. Die therapeutische Wirkung von Silymarin. Therapiewoche 34:2267–2274

    Google Scholar 

  75. Hamilton DV (1978) Carbamazepine and heart block. Lancet I/1365

    Article  Google Scholar 

  76. Handley R, Stewart ASR (1952) Mysoline: A new drug in the treatment of epilepsy. Lancet I/742–744

    Article  Google Scholar 

  77. Hansen JM, Siersbaek-Nielsen K, Kristensen M, Skovsted L, Christensen LK (1971) Effect of diphenylhydantoin on the metabolism of dicoumarol in man. Acta med Scand 189:15– 19

    Article  PubMed  CAS  Google Scholar 

  78. Hassell T, O’Donnell J, Pearlman J, Tesini D, Murphy T, Best H (1984) Phenytoin induced gingival overgrowth in institutionalized epileptics. J clin Periodontol II:242–253

    Article  Google Scholar 

  79. Hauptmann A (1912) Luminal bei Epilepsie. Münch med Wschr 69:1907–1909

    Google Scholar 

  80. Herzberg L (1978) Carbamazepine and bradycardia. Lancet I/1097–1098

    Article  Google Scholar 

  81. Hess B, Keusch G, Fluckiger J, Binswanger U (1984) Zur Pharmakokinetik von Phenytoin bei kontinuierlicher ambulanter Peritonealdialyse. 2 Fôlle und kurze Literaturübersicht. Schweiz Med Wschr 114:16–19

    PubMed  CAS  Google Scholar 

  82. Hess CW (1980) Das Carbamazepin. Schweiz Rundschau Med (Praxis) 69:803–808

    CAS  Google Scholar 

  83. Hiilesmaa VK (1983) Evaluation of placental function in women on antiepileptic drugs. Perinat Med 11:187–192

    Article  CAS  Google Scholar 

  84. Hill RM (1982) The advisability of increasing antiepileptic drug dosage during pregnancy. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 163. Raven Press, New York

    Google Scholar 

  85. Höglmeier H, Wenzel U (1969) Zerebellarer Dauerschaden durch vorübergehende Hydantoinüberdosierung. Dtsch med Wschr 94:1330–1332

    Article  PubMed  Google Scholar 

  86. Holm E, Kelleter R, Heinemann H, Hamann KF (1970) Elektrophysiologische Analyse der Wirkung von Carbamazepin auf das Gehirn der Katze. Pharmakopsychiat Neurol Psychopharmakol 3:187–200

    CAS  Google Scholar 

  87. Hruby K, Lenz K, Druml W, Kleinberger G (1982) Erfahrungen mit akuten Vergiftungen durch Carbamazepin. Nervenarzt 53:414–418

    PubMed  CAS  Google Scholar 

  88. Hüter J (1970) Übergang von Medikamenten in die Muttermilch und Nebenwirkungen beim gestillten Kind, S.29. Thieme, Stuttgart

    Google Scholar 

  89. Iivanainen M, Savolainen H (1983) Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy. Acta Neurol Scand 68, Suppl 97:49–67

    Article  Google Scholar 

  90. James MFM, Manson EDM (1985) The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med 11:5–12

    Article  PubMed  CAS  Google Scholar 

  91. Janz D (1969) Die Epilepsien. Thieme, Stuttgart

    Google Scholar 

  92. Janz D (1982) Antiepileptic drugs and pregnancy: Altered utilization pattern and teratogenesis. Epilepsia 23 (Suppl. 1):53–63

    Article  Google Scholar 

  93. Janz D, Schmidt D (1974) Anti-epileptic drugs and failure of oral contraceptives. Lancet I/1113

    Article  Google Scholar 

  94. Jeavons PM (1984) Non-dose-related side effects of valproate. Epilepsia 25 (Suppl. 1):50– 55

    Article  Google Scholar 

  95. Jensen I (1975) Temporal lobe surgery around the world. Acta Neurol Scand 52:354–373

    Article  PubMed  CAS  Google Scholar 

  96. Johnston D (1984) Valproic acid: Update on its mechanisms of action. Epilepsia 25 (Suppl. 1):1–4

    Article  CAS  Google Scholar 

  97. Karbowski K (1976) Der Petit mal-Status. Schweiz med Wschr 106:973–981

    PubMed  CAS  Google Scholar 

  98. Karbowski K, Wegmüller E (1983) Epileptische Anfälle und Myoklonien bei Niereninsuffizienz. Schweiz Rundschau Med (Praxis) 72:832–839

    CAS  Google Scholar 

  99. Kaspar U (1980) Das Diphenylhydantoin. Schweiz Rundschau Med (Praxis) 69:795–802

    CAS  Google Scholar 

  100. Klotz U, Rapp T, Müller WA (1978) Disposition of valproic acid in patients with liver disease. Eur J Clin Pharmacol 13:55–60

    Article  PubMed  CAS  Google Scholar 

  101. Knoche E, Traub E, Schuhmann RA (1983) Sofortmaßnahmen bei schwerer Präeklampsie und eklamptischem Anfall. Notfallmedizin 9:1178–1192

    Google Scholar 

  102. Koch S, Göpfert-Geyer I, Jäger-Roman E, Jakob S, Huth H, Hartmann A, Rating D, Helge H (1983) Antiepileptika während der Schwangerschaft. Eine prospektive Studie über Schwangerschaftsverlauf, Fehlbildungen und kindliche Entwicklung. Dtsch med Wschr 108:250–257

    Article  PubMed  CAS  Google Scholar 

  103. Kohl PK (1978) Das Mißbildungsrisiko der antiepileptischen Therapie. Deutsche Sektion der Intern. Liga gegen Epilepsie. Rundbrief 61:31–32

    Google Scholar 

  104. Körner E, Ladurner G, Enge S, Lechner H (1983) Hydantoinintoxikation: Klinik, Labor und EEG. Nervenarzt 54:548–552

    PubMed  Google Scholar 

  105. Kruse R (1977) Ambulante Epilepsiebehandlung. Wichtige Gesichtspunkte für die Durchführung einer medikamentösen Langzeittherapie in der Praxis. Schweiz Rundschau Med (Praxis) 66:1359–1371

    CAS  Google Scholar 

  106. Kruse R (1982) Rektale und parenterale Ersatzmedikation der antiepileptischen Langzeittherapie bei Operationen in Allgemeinanästhesie. In: Opitz A, Degen R, Kugler J (Hrsg) Anästhesie bei Epileptikern und Behandlung des Status epilepticus, p. 65–88. Editiones „Roche“

    Google Scholar 

  107. Kutt H (1984) Interactions between anticonvulsants and other commonly prescribed drugs. Epilepsia 25 (Suppl 2): 118–131

    Article  Google Scholar 

  108. Kutt H, Winters W, Scherman R, McDowell F (1964) Diphenylhydantoin and phenobarbital toxicity. The role of liver disease. Arch Neurol 11:649–656

    Article  PubMed  CAS  Google Scholar 

  109. Kutt H, Solomon GE (1980) Antiepileptic Drugs. Phenytoin: Relevant side effects. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action, p. 435–445. Raven Press, New York

    Google Scholar 

  110. Ladefoged SD, Mogelvang JC (1982) Total atrioventrikular block with syncopes complicating carbamazepine therapy. Acta Med Scand 212:185–186

    Article  PubMed  CAS  Google Scholar 

  111. Lankisch PG (1980) Akute Pankreatitis unter antikonvulsiver Therapie mit Natrium valproat (Ergenyl). Dtsch med Wschr 105:905

    PubMed  CAS  Google Scholar 

  112. Larson AW, Wasserstrom WR, Felsher BF, Shih JC (1978) Posttraumatic epilepsy and acute intermittent porphyria: Effects of phenytoin, carbamazepine and clonazepam. Neurology 28:824–828

    PubMed  CAS  Google Scholar 

  113. Laxer KD, Robertson LT, Julien RM, Dow RS (1980) Phenytoin: Relationship between cerebellar function and epileptic discharges. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol 27: p. 415–427. Raven Press, New York

    Google Scholar 

  114. Letteri JM, Mellk H, Louis S, Kitt H, Durante P, Glazko A (1971) Diphenylhydantoin metabolism in uremia. N Engl J Med 285:648–652

    Article  PubMed  CAS  Google Scholar 

  115. Levitan Z, Samberg I, Peled R, Sharf M (1983) Fetal heart rat during maternal grand mal epileptic seizures. J Foetal Med 3:59–62

    Google Scholar 

  116. Levy RH (1984) Variability in level-dose ratio of valproate: Monotherapy versus polytherapy. Epilepsia 25 (Suppl. 1): 10–13

    Article  Google Scholar 

  117. Levy RH, Moreland TA (1984) Clinical pharmacokinetics of sodium-valproate, carbamazepine and phenytoin. Schweiz Rundschau Med (Praxis) 73:159–163

    CAS  Google Scholar 

  118. Lindhout D, Höppener RJEA, Meinardi H (1984) Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of Carbamazepine). Epilepsy 25:77– 83

    Article  CAS  Google Scholar 

  119. Liponi DF, Winter ME, Tozer TN (1984) Renal function and therapeutic concentrations of phenytoin. Neurology 34:395–397

    PubMed  CAS  Google Scholar 

  120. Livingston S (1972) Comprehensive management of epilepsy in infancy, childhood and adolescence. Thomas, Springfield-Illinois

    Google Scholar 

  121. Livingston S, Petersen D, Boks LL (1955) Hypertrichosis occuring in association with Dilantin therapy. J Pediatr 47:351–352

    Article  PubMed  CAS  Google Scholar 

  122. Loiseau P (1984) Rational us of Valproate: Indications and drug regimen in epilepsy. Epilepsia 25 (Suppl l):65–72

    Article  Google Scholar 

  123. Lorgé M (1963) Klinische Erfahrungen mit einem neuen Antiepilepticum, Tegretol (G 32883), mit besonderer Wirkung auf die epileptische Wesensveränderung. Schweiz med Wschr 93:1042–1047

    Google Scholar 

  124. Lorgé M (1964) Über ein neuartiges Antiepileptikum der Iminostilbenreihe (G 32883). In: Bradley PB, Flügel F, Hock PH (eds) Proc. III Congr. Intern. Neuro-Psychopharmac. München 1962, Vol.3, p.299–302. Elsevier, Amsterdam

    Google Scholar 

  125. Magnussen CR, Doherty JM, Hess RA, Tschudy DP (1975) Grand mal seizures and acute intermittent porphyria. Neurology 25:1121–1125

    Google Scholar 

  126. Majewski F, Raff W, Fischer P, Huenges R, Petruck F (1980) Zur Teratogenität von Antikonvulsiva. Dtsch med Wschr 105:719–723

    Article  PubMed  CAS  Google Scholar 

  127. Majewski F, Steger M, Richter B, Gill J, Rabe F (1981) The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy 2:37–45

    PubMed  CAS  Google Scholar 

  128. Malherbe C, Burrill KC, Levin SR, Karam JH, Forsham PH (1972) Effect of diphenylhydantoin on insulin secretion in man. N Engl J Med 286:339–342

    Article  PubMed  CAS  Google Scholar 

  129. Mattson RH, Cramer JA (1980) Valproic and ethosuximide interaction. Ann Neurol 7:583– 584

    Article  PubMed  CAS  Google Scholar 

  130. Mauguière F, Courjon J (1983) Les effect secondaires des médicaments antiépileptiques (données recentes). Lyon méd 249:193–198

    Google Scholar 

  131. Maxwell JD (1976) Enzyme induction and drug sensitivity in hereditary hepatic porphyria. In: Richens A, Woodford FP (eds) Anticonvulsant drugs and enzyme induction, p. 137– 145. Elsevier, Amsterdam

    Google Scholar 

  132. McCarthy LJ, Aguilar JC, Ransburg R (1979) Fatal benign phenytoin lymphadenopathy. Arch Intern Med 139:367–368

    Article  PubMed  CAS  Google Scholar 

  133. Merritt HH, Putnam TJ (1938) Sodium diphenyl hydantoinate in treatment of convulsive disorders. JAMA 111:1068–1073

    Article  Google Scholar 

  134. Meunier H, Carraz G, Meunier Y, Eymard P, Aimard M (1963) Propriétés pharmacodynamiques de l’acide n-dipropylacétique. I. Propriétés antiépileptiques. Thérapie 18:435– 438

    PubMed  CAS  Google Scholar 

  135. Meyer UA (1983) Porphyrie. In: Hadorn W, Stucki P, Hess T (Hrsg) Lehrbuch der Therapie, 7. Aufl, p. 513–515. Huber, Bern-Stuttgart-Wien

    Google Scholar 

  136. Meyer UA (1985) Panhämatin. Persönliche Mitteilung aufgrund eines internen Merkblattes der Porphyriesprechstunde des Kantonsspitals Basel

    Google Scholar 

  137. Meyer-Wahl L (1980) Folsäuremangel als Mitursache für Kleinhirnatrophien bei antiepileptischer Langzeitmedikation. Nervenarzt 51:619–622

    PubMed  CAS  Google Scholar 

  138. Milonas J, Kountouris D, Scheer E (1983) Myasthenisches Syndrom nach langzeitiger Diphenylhydantoin-Therapie. Nervenarzt 54:437–438

    PubMed  CAS  Google Scholar 

  139. Nandedkar AK, Williamson R, Kutt H, Fairclough GF Jr (1980) A comparison of plasma phenytoin level determinations by EMIT and gas-liquid chromatography in patients with renal insufficiency. Ther Drug Monit 2:427–430

    PubMed  CAS  Google Scholar 

  140. Nau H, Rating D, Koch S, Häuser I, Helge H (1981) Valproic acid and its metabolites: Placental transfer, neonatal pharmacokinetics, transfer via mother’s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 219:768ä777

    PubMed  CAS  Google Scholar 

  141. Nau H, Kuhnz W, Egger HJ, Rating D, Helge H (1982) Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet 7:508–543

    Article  PubMed  CAS  Google Scholar 

  142. Niebyl JR, Blake DA, Freeman JM, Luff RP (1979) Carbamazepine levels in pregnancy and lactation. Obstet Gynecol 53:139–140

    PubMed  CAS  Google Scholar 

  143. Niedermeyer E (1984) Awakening epilepsy („Aufwach-Epilepsie“) revisited 30 Years later. In: Degen R, Niedermeyer E (eds) Epilepsy, Sleep and Sleep Deprivation, p. 85–94. Elsevier, Amsterdam-New York-Oxford

    Google Scholar 

  144. Opitz A (1982) Zerebrale Krampfanfälle und Hypnoanalgetika. In: Opitz A, Degen R, Kugler J (Hrsg) Anästhesie bei Epileptikern und Behandlung des Status epilepticus, p. 39– 46. Editiones „Roches“ 1982

    Google Scholar 

  145. Orme M (1983) Oral contraceptives and anticonvulsant drugs. In: Jeavons PM, Anfield L (eds) Third International Symposium on Sodium Valproate. Br J Clin Pract, Symp Suppl 27:26–30

    Google Scholar 

  146. Parker PH, Helinek GL, Ghishan FK, Greene HL (1981) Recurrent pancreatitis induced by valproic acid. A case report and review of the literature. Gastroenterology 80:826–828

    PubMed  CAS  Google Scholar 

  147. Perry-Keene DA, Larkins RG, Heyma P, Peter CT, Ross D, Sloman JG (1980) The effect of long-term diphenylhydantoin therapy on glucose tolerance and insulin secretion: A controlled trial. Clin Endocrinol (Oxford) 12:575–580

    Article  CAS  Google Scholar 

  148. Perucca E, Richens A (1981) Drugs interactions with phenytoin. Drugs 21:120–137

    Article  PubMed  CAS  Google Scholar 

  149. Plochl E (1983) Leberkoma mit letalem Ausgang bei zwei Kindern unter antiepileptischer Dauertherapie. Padiatr Padol 18:57–63

    PubMed  CAS  Google Scholar 

  150. Prichard JW (1980) Phenobarbital: Introduction. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neuroloy, Vol.27: p. 473–491. Raven Press, New York

    Google Scholar 

  151. Prichard JW (1980) Phenobarbital: Proposed mechanisms of antiepileptic action. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol. 27: p. 553–562. Raven Press, New York

    Google Scholar 

  152. Pynnönen S, Sillanpää M (1975) Carbamazepine and mother’s milk. Lancet II/563

    Article  Google Scholar 

  153. Rassmussen T (1975) Surgery of frontal lobe epilepsy. In: Purpura DP, Penry JK, Walter RD (eds) Neurosurgical Management of the Epilepsies, p. 197–205. Advances in Neurology, Vol 8. Raven Press, New York

    Google Scholar 

  154. Rassmussen T (1983) Hemispherectomy for seizures revisited. Can J Neurol Sci 10:71–78

    Google Scholar 

  155. Rating D (1985) Zum Mißbildungsrisiko einer Antiepileptika-Therapie in der Schwanger-schaft. Schweiz Rundschau Med (Praxis) 74:655–659

    CAS  Google Scholar 

  156. Rating D, Nau H, Kuhnz W, Jäger-Roman E, Helge H (1983) Antiepileptika in der Neugeborenenperiode. Monatschr Kinderheilk 131:6–12

    CAS  Google Scholar 

  157. Rawson MB (1968) Diphenylhydantoin intoxication and cerebrospinal fluid protein. Neurology 18:1009–1011

    PubMed  CAS  Google Scholar 

  158. Reith H, Schäfer H (1979) Antiepileptika während Schwangerschaft und Stillzeit. Dtsch med Wschr 104:818–823

    Article  PubMed  CAS  Google Scholar 

  159. Reynolds NC Jr (1982) Seizure management and hepatic porphyrias. Letter to the editor. Neurology 32:1409–1410

    PubMed  CAS  Google Scholar 

  160. Reynolds NC Jr, Miska RM (1981) Safety of anticonvulsants in hepatic porphyrias. Neurology 31:480–484

    PubMed  Google Scholar 

  161. Richens A (1976) Liver enzyme induction by antiepileptic drugs: Its clinical significance. In: Richens A, Woodford FP (eds) Anticonvulsant Drugs and Enzym Induction, p. 3–12. Elsevier, Amsterdam

    Google Scholar 

  162. Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet II/937

    Article  Google Scholar 

  163. Rossi L, Bonuccelli U, Maracacci G, Bindi A, De Scisciolo G, Arena R (1983) Gynecomastia in epileptics treatment with phenobarbital, phenytoin and fluoresone: two case reports. Ital J Neurol Sci 4:207–210

    Article  PubMed  CAS  Google Scholar 

  164. Sandyk R (1983) Transient hemiparesis - a rare complication of phenytoin-toxicity. Postgrad Med J 59:601–602

    Article  PubMed  CAS  Google Scholar 

  165. Schmidt D (1982) The effect of Pregnancy of the natural history of epilepsy: Review of the literature. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 3–14. Raven Press, New York

    Google Scholar 

  166. Schmidt D (1984) Behandlung der Epilepsien, 2. Aufl. Thieme, Stuttgart-New York

    Google Scholar 

  167. Schmidt D (1984) Adverse effects of Valproate. Epilepsia 25 (Suppl. 1):44–49

    Article  Google Scholar 

  168. Schmidt D, Vogel A (1977) Plasmakonzentrationen nach Injektion und Infusion von Phenytoin. Klin Wschr 55:219–223

    Article  PubMed  CAS  Google Scholar 

  169. Schmidt D, Canger R, Avanzini G, Battino D, Cusi C, Beck-Mannagetta G, Koch S, Rating D, Janz D (1983) Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiat 46:751–755

    Article  PubMed  CAS  Google Scholar 

  170. Schneble H (1981) SGPT und Gamma-GT bei Patienten mit antikonvulsiver Therapie unter besonderer Berücksichtigung der Serumkonzentrationen der Antiepileptika. Med Welt 32:427–431

    PubMed  CAS  Google Scholar 

  171. Schwartau M, Wahl G, Bucking J (1983) Intramyokardialer Block bei Carbamazepin-In-toxikation. Dtsch Med Wschr 108:1841–1843

    Article  PubMed  CAS  Google Scholar 

  172. Schweingruber R (1980) Die Barbiturate. Schweiz Rundschau Med (Praxis) 69:790–794

    CAS  Google Scholar 

  173. Selhorst JB, Kaufman B, Horwitz SJ (1972) Diphenylhydantoin induced cerebellar degeneration. Arch Neurol (Chicago) 27:453–455

    Article  CAS  Google Scholar 

  174. Serrano EE, Roye DB, Hammer RH, Wilder BJ (1973) Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin. Neurology 23:311–317

    PubMed  CAS  Google Scholar 

  175. Serrano EE, Wilder BJ (1974) Intramuscular administration of diphenylhydantoin. Arch Neurol 31:276–278

    Article  PubMed  CAS  Google Scholar 

  176. Sheridan WP, King RW, Gerstman M (1982) Fever as an adverse reaction to carbamazepine. Aust NZJ Med 12:520–522

    Article  CAS  Google Scholar 

  177. Shervin AL, Robb JP (1972) Ethosuximide. Relation of plasma level to clinical control (continued). In: Woodbury DM, Penry JK, Schmidt RP (eds) Antiepileptic Drugs, p. 443– 448. Raven Press, New York

    Google Scholar 

  178. Sidiropoulos D (1982) Pränatale Diagnostik von angeborenen Anomalien. Pädiat Fort-bildk Praxis Bd 53, p. 128–145. Karger, Basel

    Google Scholar 

  179. Simila S, Wendt von L., Linna SL (1980) Dipropylacetate and aminoaciduria. J Neurol Sci 45:83–86

    Article  PubMed  CAS  Google Scholar 

  180. Sonnen AEH (1980) Hormonelle Kontrazeption, antikonvulsive Therapie und Epilepsie-verlauf. In: Doose H et al (Hrsg) Epilepsie 1979. Ehe, Schwangerschaft, Geburt, genetische Beratung, p. 86–94. Thieme, Stuttgart-New York

    Google Scholar 

  181. Srinivasan G, Seeler RA, Tiruvury A, Pildes RS (1982) Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol 59:250–252

    PubMed  CAS  Google Scholar 

  182. Stempel LE, Moore TD (1982) Anticonvulsant therapy during pregnancy. In: Rayburn WF, Zuspan FP (eds) Drug Therapy in Obstetrics and Gynecology, p. 43–64. Rayburn, Norwalk Appelton-Century-Crofts

    Google Scholar 

  183. Sullivan JB Jr, Rumack BH, Peterson RG (1981) Acute carbamazepine toxicity resulting from overdose. Neurology 31:621–624

    PubMed  Google Scholar 

  184. Suria A, Killam EK (1980) Carbamazepine. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol.27: p. 563–575. Raven Press, New York

    Google Scholar 

  185. Swift TR, Gross JA, Ward LC, Crout BO (1981) Peripheral neuropathy in epileptic patients. Neurology 31:826–831

    PubMed  CAS  Google Scholar 

  186. Taylor RL (1981) Magnesium sulfate for AIP seizures. Neurology 31:1371–1372

    PubMed  CAS  Google Scholar 

  187. Teramo K, Hiilesmaa V, Bardy A, Saarikoski S (1979) Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 7:3–6

    Article  PubMed  CAS  Google Scholar 

  188. Teramo K, Hiilesmaa VK (1982) Pregnancy and fetal complications in epileptic pregnancies: Review of the literature. In: Janz D et al (eds) Epilepsy, Pregnancy and the Child, p. 53–59. Raven Press, New York

    Google Scholar 

  189. Tomsick RS (1983) The phenytoin syndrome. Cutis 32:535–541

    PubMed  CAS  Google Scholar 

  190. Van der Starre P (1980) Etomidat als schnellwirkende antiepileptische Substanz. In: Opitz A, Degen R (Hrsg) Anästhesie bei zerebralen Krampfanfällen und Intensivtherapie des Status epilepticus, p. 205–208. Perimed-Fachbuch-Verlagsgesellschaft, Erlangen

    Google Scholar 

  191. Van Wieringen A, Vrijland CM (1983) Ethosuximide intoxication caused by interaction with isoniazid. Neurology 33:1227–1228

    PubMed  Google Scholar 

  192. Vassella F (1977) Gelegenheitskrämpfe. Schweiz Rundschau Med (Praxis) 66:1331–1337

    CAS  Google Scholar 

  193. Vassella F (1982) Phenytoin (DPH) in der Padiatrie. Sozialpädiatrie in Praxis u. Klinik 4:87–90

    Google Scholar 

  194. Vassella F (1984) Medikamentöse Behandlung der Epilepsie. In: Berner Datenbuch der Pädiatrie, p. 558–565. Fischer, Stuttgart-New York

    Google Scholar 

  195. Vassella F, Pfenninger J (1975) Chemotherapie der Infektionskrankheiten im Säuglings-und Kindesalter. Schweiz med Wschr 105:263–266

    PubMed  CAS  Google Scholar 

  196. Vossen R (1958) Über die antikonvulsive Wirkung von Succinimiden. Dtsch med Wschr 83:1227–1230

    Article  PubMed  CAS  Google Scholar 

  197. Ware S, Millward-Sadler GH (1980) Acute liver disease associated with sodium valproate. Lancet II/1110–1113

    Article  Google Scholar 

  198. Warter JM, Brandt C, Maresceaux C, Rumbach L, Micheletti G, Chabrier G, Krieger J, Imler M (1983) The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Neurology 33:1136–1140

    PubMed  CAS  Google Scholar 

  199. Warter JM, Imler M, Marescaux C, Chabrier G, Rumbach L, Micheletti G, Krieger J (1983) Sodium valproate-induced hyperammonemia in the rat. Role of the kidney. Eur J Pharmacol 87:177–182

    Article  PubMed  CAS  Google Scholar 

  200. Watson DL, Sibai BM, Shaver DC, Dacus JV, Anderson GD (1983) Late postpartum eclampsia: An update. South Med J 76:1487–1489

    Article  PubMed  CAS  Google Scholar 

  201. Wauquier A (1983) Profil of etomidate. A hypnotic, anticonvulsant and brain protective compound. Anaesthesia 38 (Suppl):26–33

    Article  PubMed  CAS  Google Scholar 

  202. Wieser HG (1985) Derzeitige Möglichkeiten der operativen Epilepsiebehandlung. Nervenarzt 56: Im Druck

    Google Scholar 

  203. Wieser HG, Yasargil MG (1982) Die „selektive Amygdala-Hippokampektomie“ als chirurgische Behandlungsmethode der mediobasal-limbischen Epilepsie. Neurochirurgie 25:39– 50

    CAS  Google Scholar 

  204. Wilder BJ, Ramsay RE, Murphy JV, Karas BJ, Marquardt K, Hammond EJ (1983) Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology 33:1474–1476

    PubMed  CAS  Google Scholar 

  205. Wilensky AJ, Lowden JA (1973) Inadequate serum levels after intramuscular administration of diphenylhydantoin. Neurology 23:318–324

    PubMed  CAS  Google Scholar 

  206. Wolf P, Inoue Y, Räder-Wanner UU, Tsai JJ (1984) Psychiatric complications of absence therapy and their relation to alteration of sleep. Epilepsia 25:556–559

    Article  Google Scholar 

  207. Woodbury DM (1972) Bromides. In: Woodbury DM, Penry JK, Schmidt RP (eds) Anti-epileptic Drugs, p. 519–527. Raven Press, New York

    Google Scholar 

  208. Woodbury DM (1980) Phenytoin: Proposed mechanisms of anticonvulsant action. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic Drugs: Mechanisms of Action. Advances in Neurology, Vol 27:447–471. Raven Press, New York

    Google Scholar 

  209. Yeung Laiwah AAC, Rapeport WG, Thomson GG, Macphee GJA, Philip MF, Moore MR, Brodie MJ, Goldberg A (1983) Carbamazepine-induced non-hereditary porphyria. Lancet I/790–793

    Article  Google Scholar 

  210. Zackai EH, Mellman WJ, Neiderer B, Hanson JW (1975) The fetal trimethadione syndrome. J Pediatr 87:280–284

    Article  PubMed  CAS  Google Scholar 

  211. Zimmerman FT, Burgemeister BB (1958) A new drug for petit mal epilepsy. Neurology 8:769–775

    PubMed  CAS  Google Scholar 

  212. Zysset T, Bircher J (1980) Verbesserte Dosierung von Antiepileptika mit Hilfe von Konzentrationsmessungen im Plasma. Schweiz Rundschau Med (Praxis) 69:835–839

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chefarzt an der Neurologischen Universitätsklinik, Inselspital, Bern, CH-3010, Switzerland

    Prof. Dr. Kazimierz Karbowski

Authors
  1. Prof. Dr. Kazimierz Karbowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Karbowski, K. (1985). Antiepileptische Therapie. In: Epileptische Anfälle. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82558-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82558-3_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-15614-7

  • Online ISBN: 978-3-642-82558-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation